SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036845
Filing Date
2020-08-05
Accepted
2020-08-05 16:22:04
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q2 2020 harp-10q_20200630.htm 10-Q 2802905
2 EX-10.1 harp-ex101_27.htm EX-10.1 19394
3 EX-10.2 harp-ex102_28.htm EX-10.2 20276
4 EX-31.1 harp-ex311_8.htm EX-31.1 17899
5 EX-31.2 harp-ex312_6.htm EX-31.2 18847
6 EX-32.1 harp-ex321_7.htm EX-32.1 7089
7 GRAPHIC gaj2r2vqbjeb000001.jpg GRAPHIC 6756
  Complete submission text file 0001564590-20-036845.txt   9065459

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT harp-20200630.xml EX-101.INS 2141413
9 XBRL TAXONOMY EXTENSION SCHEMA harp-20200630.xsd EX-101.SCH 49437
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20200630_cal.xml EX-101.CAL 44570
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20200630_def.xml EX-101.DEF 167457
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20200630_lab.xml EX-101.LAB 387117
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20200630_pre.xml EX-101.PRE 292049
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 201077645
SIC: 2836 Biological Products, (No Diagnostic Substances)